Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Subscribe To Our Newsletter & Stay Updated
